BANCO BILBAO VIZCAYA ARGENTARIA, S.A.
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 842180
Madrid, U3
Position in BCRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$183,250
+$33,108 QoQ
Shares Held
19,249
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BANCO BILBAO VIZCAYA ARGENTARIA, S.A. holds $13,535,547 across 6 Drug Manufacturers - Specialty & Generic names. BCRX ranks #6 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
142,241 | $5,368,175 | |
| 2 | VTRS |
Viatris Inc
|
280,376 | $3,787,879 | |
| 3 | ZTS |
Zoetis Inc.
|
30,722 | $3,631,647 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
610 | $361,717 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,540 | $202,879 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
19,249 | $183,250 |
All Filings in BCRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $183,250 | 19,249 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $150,142 | 19,249 | Shares | Defined | 2026-02-17 | |
| 2020-06-30 | $460,768 | 96,800 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $193,600 | 96,800 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||